Medical countermeasures are required to address the emerging radiological and nuclear threats. In 2005-2006, the National Institute of Allergy and Infectious Diseases (NIAID), biodefense and related program, and Armed forces Radiobiology Research Institute (AFRRI), a premier DOD Radiobiology Research Institute, established an Interagency agreement to facilitate discovery and development of radiation countermeasures. These agents were derived from pharmaceutical companies, industry, and scientists from Institutions of higher learning and tested in mouse model against injury from cobalt-60 gamma ionizing radiations at AFRRI. Several classes of compounds (~40) such as nutraceuticals (vitamin E isomers), growth factors (Granulocyte Colony Stimulating Factor ?G-CSF), signal transduction agents, and immunomodulators have been evaluated since 2006-present.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$764,812
Indirect Cost
Name
Office of the Director, National Institutes of Health
Department
Type
DUNS #
City
State
Country
Zip Code